The core problem in 340B runs deeper than poor oversight. The law requires steep discounts for purchased drugs but does not specify that the savings should be passed on to patients and insurance ...

SCOTTSDALE, AZ--(Marketwire -08/21/12)- The National Council for Prescription Drug Programs (NCPDP) is hosting an educational webinar on how new changes to its Telecommunication Standard will impact ...

(Reuters) - Eli Lilly said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking the company's plan to change the way it offers drug discounts to ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. The Trump administration unveiled a string of new healthcare ...

The 340B Drug Pricing Program (340B program) is a federal drug discount program that requires drug manufacturers participating in the Medicaid drug rebate program to provide outpatient drugs to ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "MFN reinforces the worst incentives in 340B, shifts costs ...

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills. By Ellen Gabler Soon after being diagnosed with metastatic breast ...

The 340B drug discount program dates back to President George H.W. Bush, and it's a lifeline for rural Kansas hospitals and their patients. Topeka Capital-Journal file photo Kansas Sen. Jerry Moran ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...